Pharmacogenomics and the Pharmaceutical Industry: A New Frontier for Business Leaders
Pharmacogenomics and the Pharmaceutical Industry
Pharmacogenomics and the Pharmaceutical Industry
Have you pondered the potential of a customized medication plan to significantly enhance health outcomes for those managing numerous medications? In an era…
Did you know that 16.8% of U.S. patients are exposed to multiple drugs with available pharmacogenomic guidelines1? This statistic highlights the pivotal role…
Imagine if your DNA could show you the perfect drug for you. This idea is at the core of pharmacogenomics. It’s changing medicine…
Rare diseases are a significant global health challenge, affecting millions worldwide. In the US, 30 million people, and in the EU, 36 million,…
Pharmacogenomics heralds a revolutionary shift in modern medicine, focusing on tailoring drug therapies to an individual’s genetic profile. This field is revolutionizing healthcare,…
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Adverse drug reactions (ADRs) pose a substantial challenge within the pharmaceutical sector, with over 106,000 fatalities annually in the United States, according to…
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx